BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yetkin-Arik B, Kastelein AW, Klaassen I, Jansen CHJR, Latul YP, Vittori M, Biri A, Kahraman K, Griffioen AW, Amant F, Lok CAR, Schlingemann RO, van Noorden CJF. Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy. Biochim Biophys Acta Rev Cancer 2021;1875:188446. [PMID: 33058997 DOI: 10.1016/j.bbcan.2020.188446] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Tian W, Yue D, Chen C, Li C, Zhang Z, Wang C. Bevacizumab-Induced Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and ERK Inactivation Contribute to Cardiotoxicity. Oxid Med Cell Longev 2021;2021:5548130. [PMID: 33859777 DOI: 10.1155/2021/5548130] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zakrzewski PK. Canonical TGFβ Signaling and Its Contribution to Endometrial Cancer Development and Progression-Underestimated Target of Anticancer Strategies. J Clin Med 2021;10:3900. [PMID: 34501347 DOI: 10.3390/jcm10173900] [Reference Citation Analysis]
3 Zhang C, Liu N. N6-methyladenosine (m6A) modification in gynecological malignancies. J Cell Physiol 2022. [PMID: 35802474 DOI: 10.1002/jcp.30828] [Reference Citation Analysis]
4 Wieder-Huszla S, Owsianowska J, Chudecka-Głaz A, Branecka-Woźniak D, Jurczak A. The Significance of Adaptation and Coping with Disease among Patients with Diagnosed Gynaecological Cancer in the Context of Disease Acceptance. Int J Environ Res Public Health 2022;19:7218. [PMID: 35742468 DOI: 10.3390/ijerph19127218] [Reference Citation Analysis]
5 Ma C, Ma RJ, Hu K, Zheng QM, Wang YP, Zhang N, Sun ZG. The molecular mechanism of METTL3 promoting the malignant progression of lung cancer. Cancer Cell Int 2022;22:133. [PMID: 35331234 DOI: 10.1186/s12935-022-02539-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Giuli MV, Mancusi A, Giuliani E, Screpanti I, Checquolo S. Notch signaling in female cancers: a multifaceted node to overcome drug resistance. Cancer Drug Resist 2021;4:805-36. [PMID: 35582386 DOI: 10.20517/cdr.2021.53] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tan S, Zang G, Wang Y, Sun Z, Li Y, Lu C, Wang Z. Differences of Angiogenesis Factors in Tumor and Diabetes Mellitus. Diabetes Metab Syndr Obes 2021;14:3375-88. [PMID: 34335038 DOI: 10.2147/DMSO.S315362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Sun W, Zhou H, Han X, Hou L, Xue X. Circular RNA: A novel type of biomarker for glioma (Review). Mol Med Rep 2021;24:602. [PMID: 34165178 DOI: 10.3892/mmr.2021.12240] [Reference Citation Analysis]
9 Li S. Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma. Front Oncol 2021;11:664853. [PMID: 34094958 DOI: 10.3389/fonc.2021.664853] [Reference Citation Analysis]
10 Tantari M, Bogliolo S, Morotti M, Balaya V, Bouttitie F, Buenerd A, Magaud L, Lecuru F, Guani B, Mathevet P, On Behalf Of The Senticol Group. Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study. Cancers (Basel) 2022;14:212. [PMID: 35008376 DOI: 10.3390/cancers14010212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]